7-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98+%, 1g

2-(Furan-2-yl)-6-nitroquinoline-4-carboxylic acid, 95%, 50mg

2',4',5'-Trimethylpropiophenone, 97.0%, 1g

2-(4-Bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine, 95.0%, 100mg

2-(3-(TERT-BUTOXYCARBONYL)-3-AZABICYCLO[3.2.1]OCTAN-8-YL)ACETIC ACID, 95.0%, 1g

3-Fluorophthalic anhydride, 97.0%, 100g

6,8-Dimethoxy-4-methylquinoline>98.0%(GC)(T)1g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2,2,2-trifluoroethoxy)pyridine, 98%, 100mg

(S)-2,6-Diaminohexanoic acid compound with (S)-2-aminosuccinic acid (1:1), 95.0%, 1kg

5-(4-Isopropylphenyl)thiophene-2-carboxylic acid, 95.0%, 1g

cyclobutyl 2-(2,3-dimethylphenyl)ethyl ketone, 97.0%, 1g

(R)-4,4-DIMETHYL-PYRROLIDINE-2-CARBOXYLIC ACID, 95.0%, 500mg

2-(2-Nitrophenyl)pyridine, 96%, 25mg